In vitro fluoroquinolone-resistant mutants of Salmonella enterica serotype Enteritidis: analysis of mechanisms involved in resistance

Int J Antimicrob Agents. 2003 Nov;22(5):537-40. doi: 10.1016/s0924-8579(03)00241-3.

Abstract

This study analysed the mechanisms involved in the acquisition of resistance to quinolones in mutants obtained in vitro of Salmonella enterica serotype Enteritidis. Two nalidixic acid-resistant (minimal inhibitory concentrations, MIC>256 mg/l), ciprofloxacin-susceptible (MIC 0.5 mg/l) clinical isolates of Salmonella Enteritidis with a mutation at amino acid codon Ser-83 of the gyrA gene were grown on plates containing increasing concentrations of ciprofloxacin. The increase in MIC to ciprofloxacin, sparfloxacin and trovafloxacin was totally or partially associated with over-expression of an AcrAB-like efflux pump. In addition, unidentified mechanism(s) may have been involved in the increased MIC to these antimicrobials. This study demonstrated that AcrAB-like efflux pumps appear to play a relevant role in the increase in MIC to some quinolones although, other, as yet undefined, mechanisms may be involved.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ciprofloxacin / pharmacology
  • DNA Gyrase / genetics*
  • DNA Gyrase / physiology
  • Drug Resistance, Bacterial / genetics*
  • Fluoroquinolones / pharmacology*
  • Humans
  • In Vitro Techniques
  • Microbial Sensitivity Tests
  • Nalidixic Acid / pharmacology
  • Salmonella enterica / drug effects*
  • Salmonella enterica / genetics

Substances

  • Fluoroquinolones
  • Nalidixic Acid
  • Ciprofloxacin
  • DNA Gyrase